Thymosin Alpha-1 (Tα1), also known as thymalfasin, is a naturally occurring 28-amino-acid peptide associated with immune-system regulation and immunological get more info signaling. It has been extensively researched for its potential effects on innate and adaptive immune responses.
Research has investigated Thymosin Alpha-1 in areas including immune modulation, infectious disease, inflammatory pathways, and cancer-related research.
Product Highlights
Contains Thymosin Alpha-1 (Tα1)
28-amino-acid peptide
Studied for immune-system signaling and modulation
Researched in infectious-disease and inflammatory pathways
Investigated in immunology and oncology research
Suitable for research-focused peptide collections where permitted
Potential Research Benefits
Immune-system modulation
Tα1 has been studied for its ability to regulate both innate and adaptive immune responses.
T-cell function
Research has examined effects on T-cell activity, differentiation, and immune responses.
Dendritic-cell activity
Tα1 can influence dendritic-cell signaling, which is important for coordinating immune responses.
Infectious-disease research
It has been investigated as an immunomodulatory adjunct in various infectious diseases and antiviral research. However, clinical effectiveness varies by condition.
Cancer-immunology research
Tα1 has been studied alongside chemotherapy, radiotherapy, targeted therapies, and immune checkpoint inhibitors. A 2026 review found encouraging signals in some studies but emphasized that the clinical evidence remains heterogeneous and that more controlled research is needed.
Inflammatory and immune-signaling research
Studies have examined its effects on cytokines, chemokines, Toll-like receptor pathways, and mechanisms involved in balancing inflammation and immune tolerance.
Vaccine-response research
Tα1 has also been investigated as an adjunct intended to influence immune responses to vaccination, particularly in populations with impaired immune responses.